Acclimatization of Healthy Subjects During a Stay at 3200 m

NCT ID: NCT02451020

Last Updated: 2018-10-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-06-08

Study Completion Date

2015-08-09

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study evaluates respiratory acclimatization in healthy lowlanders staying for 3 weeks at 3200 m.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study evaluates the effect of 3 weeks altitude acclimatization on sleep related breathing disturbances in healthy subjects staying at 3200 m. Participants living in Bishkek, Kyrgyzstan (700 m), will be transferred by car within 4 h to the Tuja Ashu high altitude clinic (3200 m). Outcomes will be assessed repeatedly during the stay at 3200 m.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Effects of High Altitude

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Altitude exposure

Stay at 3200 m for 3 weeks

Group Type EXPERIMENTAL

Altitude exposure

Intervention Type OTHER

Participants will stay for 3 weeks at an altitude of 3200 m

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Altitude exposure

Participants will stay for 3 weeks at an altitude of 3200 m

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Perfect health
* Born, raised and currently living at low altitude (\<800m)
* Informed consent.

Exclusion Criteria

* Any acute or chronic disease
* heavy smoking (\>20 cigarettes per day).
Minimum Eligible Age

20 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Center of Cardiology and Internal Medicine named after academician M.Mirrakhimov

OTHER_GOV

Sponsor Role collaborator

University of Zurich

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Konrad E Bloch, MD

Role: STUDY_CHAIR

University Hospital, Zürich

Talant M Sooronbaev, MD

Role: STUDY_DIRECTOR

National Center of Cardiology and Internal Medicine, Bishkek, Kyrgyzstan

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

National Center of Cardiology and Internal Medicine

Bishkek, , Kyrgyzstan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Kyrgyzstan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EK15-2015_V2

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Exercise After an ICD
NCT00522340 COMPLETED PHASE2
Exercise Effects on Atrial Fibrillation
NCT06607510 NOT_YET_RECRUITING NA